Atlas Trials

Real-World Study on the Safety and Effectiveness of IL-23 Inhibitors for Inflammatory Bowel Disease in China

Clinical trial NCT07184138 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07184138
Sponsor
Sixth Affiliated Hospital, Sun Yat-sen University
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
Inflamatory Bowel Disease (Crohn's and Ulcerative Colitis)
Start date
2025-10-01
Primary completion
2028-10-01
Enrollment
178

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.